Prenatal Opioid Exposure Linked to Higher Hospitalization

Children exposed to maternal opioids before birth may face an increased risk of hospital admission in their first five years.

Updated on Oct. 13, 2026 in Pregnancy

Prenatal Opioid Exposure Linked to Higher Hospitalization

Live Poll

Should medical providers further restrict opioid prescriptions for pregnant women based on new safety data?

A large study tracking millions of children found that prenatal opioid exposure is associated with a 28% higher rate of hospital admissions in early childhood. This elevated risk is most pronounced for children up to five years of age.

Why it matters

Researchers suggest that prenatal opioid exposure could disrupt early development and immune system function, leading to a higher prevalence of infections and respiratory, gastrointestinal, or genitourinary conditions. These findings underscore the need for enhanced postnatal health monitoring for children with a history of prenatal opioid exposure.

This cohort study analyzed health data for 2,928,186 children born between 2010 and 2017. Findings showed that children exposed to two or more maternal opioid prescriptions had a 28% higher hospital admission rate, with risks increasing alongside maternal dose intensity.

The players

PLOS Medicine

An open-access medical journal that publishes original research and commentary on health and medical science.

The details

Researchers tracked outcomes by comparing admission rates between children with documented prenatal opioid exposure and unexposed peers, as well as by conducting sibling comparisons to control for familial factors. The study suggests that opioids may interfere with fetal development and the maturation of the infant immune system. Higher maternal doses were found to correlate with more frequent hospitalizations for specific conditions, including gastrointestinal and respiratory issues.

Timeline

  1. Children included in the study were born between 2010 and 2017.

  2. The study findings were published on October 13, 2026.

Health Landscape

With 14% to 22% of pregnant women in the United States filling opioid prescriptions, this research adds significant weight to concerns regarding the long-term pediatric implications of these clinical practices. The results represent a shift toward prioritizing extended developmental monitoring for this population.

If you or your child had prenatal opioid exposure, discuss the findings of this study with your pediatrician to determine if additional monitoring is warranted. Being aware of the increased risk for infections and respiratory conditions can help you identify symptoms early.

The takeaway

Prenatal opioid exposure is associated with a notable increase in hospitalizations throughout early childhood, particularly for infections and respiratory ailments. Parents and guardians should consult a primary care physician to discuss tailored wellness checkups for children with a history of prenatal exposure.

Further reading

For more information on health during pregnancy and development, visit the Pregnancy section.

More information

Read the complete journal study on prenatal opioid exposure for detailed findings.

Live Poll

Should medical providers further restrict opioid prescriptions for pregnant women based on new safety data?